Moreover, Mougey et al. (2019) [21] conducted a prospective study whose objective was to determine the influence of genetic variation of two genes including CYP2C19 on the treatment of eosinophilic esophagitis by PPIs. Here, CYP2C19 is linked to eosinophilic esophagitis.